RxDoctor Payments DataLook up a doctor →

Kimberly Ryan, APRN

Adult Health · Wethersfield, CTNPI 1124323472

Payments from drug & device makers

$73,565in general payments, 2019–2025

Across 849 payments — averaging $86.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$58K
  • Johnson & Johnson$1K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Novartis$1K
  • Rigel Pharmaceuticals, Inc.$804
  • Bayer$795
  • plus $11K from 46 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)129$57,577
Johnson & Johnson(2 entities)60$1,456
E.r. Squibb & Sons, L.L.C.52$1,290
Novartis49$1,075
Rigel Pharmaceuticals, Inc.37$804
Bayer28$795
Merck41$775
Pfizer50$757
Lilly USA, LLC29$733
Incyte Corporation21$607
Gilead(2 entities)19$577
Jazz Pharmaceuticals Inc.32$561
Sanofi27$518
Bristol Myers Squibb33$483
Beigene USA, Inc.12$400
Genentech USA, Inc.19$383
Seagen Inc.13$355
Exelixis Inc.17$353
Astellas Pharma US Inc15$315
GSK13$303
Takeda Pharmaceuticals U.S.A., Inc.10$288
Amgen7$259
Epizyme, Inc.10$243
Geron Corporation10$237
Pharmaessentia USA Corporation9$214
Daiichi Sankyo Inc.10$209
ADC Therapeutics America, Inc.10$208
Array Biopharma Inc9$173
AbbVie7$165
Stemline Therapeutics Inc.8$161
Mirati Therapeutics, Inc.8$152
Pharmacyclics LLC, An Abbvie Company5$134
Sobi, Inc7$133
Eisai Inc.6$113
Beone Medicines USA, Inc.4$113
Servier Pharmaceuticals LLC5$101
Myriad Genetic Laboratories, Inc.5$89
Regeneron Healthcare Solutions, Inc.3$55
Springworks Therapeutics, Inc.3$53
Puma Biotechnology, Inc.3$48
Organon2$45
Boehringer Ingelheim2$43
Taiho Oncology, Inc.1$31
Avyxa Pharma, LLC1$30
Acrotech Biopharma Inc.1$26
Dendreon Pharmaceuticals LLC1$24
Blueprint Medicines Corporation1$21
Azurity Pharmaceuticals, Inc.1$19
Coherus Oncology, Inc.1$18
Morphosys, US Inc.1$18
Biocon Biologics Inc1$15
Cumberland Pharmaceuticals, Inc.1$13

How this compares

$73,565 in reported general payments places this provider in the 95th percentile of 418 adult health providers in Connecticut.

See all adult health providers in Connecticut →

Medicare billing

Part B allowed, 2024
$316,253
Medicare patients
250
Services billed
9,524

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Wethersfield

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →